Transcript Health

Health Economy
in Northern Germany
and the Baltic Sea Region:
what is in for the regions?
Using Nordic-European synergies in co-operation
Conference Smart Growth – Smart Specialisationin the BSR
Malmö, Sweden 5-6 April 2011
Wolfgang Blank, BioCon Valley GmbH & ScanBalt fmba
Trends …
Steel
Railway
Electronics
Chemistry
1900
1950
Petroindustry
Automobile
Life Sciences
Information
Psychosocial
Source: NY Times, 2008
Computer
health
1980
2000
Source: Der Spiegel, 2008
Opportunities & challenges:
• Scientific progress (stem cell research,
molecular biology, diagnostics)
• Growing health awareness
• Ageing society
• Stability of social health care systems
2010
Life style
2005-06
Bildquelle:www.keinfastfood.de
Source: HBSC Survey 20052006, Currie et al. (2008).
Source: OECD Health Data 2009, OECD
(http://www.oecd.org/health/healthdata).
Demographic development
Rostock
Schwerin
Greifswald
 North Eastern Germany
 Located in between
metropolitan areas Berlin,
Hamburg, Copenhagen
 Population approx.
1,8 million (= Hamburg)
 Area approx. 23.000 km ²
 Approx. 80 inhabitants /km ²
 Rostock largest city
(200.000 habitants)
 Maritime countryside with
more than 1.000 km coast
line and more than 1000
lakes
Development of senior population 65+
„Eldest
Federal State“
Comparison Germany vs. Mecklenburg-Vorpommern
30
Ratio (in %)
Ger
M-V
26,5
25
20,1
20
15
10
22,3
22
17,5 16,9
14,9
10,6
5
0
1989
„Youngest
Federal State“
2002
2012
Year
2020
© ICM EMAU 2006
Quelle: Stat. Landesamt M-V, 2003, Prof. Hoffmann
Age-related diseases in M-V
Comparison 2002 vs. 2020
Men
Women
Diabetes Type II
+ 20%
(8.800)
+ 1% (500)
Coronary diseases, ...
+ 48%
(1.600)
+ 32% (900)
Stroke
Cancer
Dementia
+ 53% (700) + 27% (550)
+ 36%
(1.750)
+ 13% (550)
+ 67% (11.500)
© ICM EMAU 2006
From challenges
to opportunities
Dürer´s mother, 1514
Nordic VIP´s, ~ 2010
„Healthy“ Ageing
Each second,
today born girl
will have
the opportunity
to celebrate
her
100th birthday!
Senior workforce
 Vita Needle Inc.
 95% of staff senior
citizens (part-time)
 Average age 73
 Some examples:
 Rosa Finnegan,
93, 9 years
 Bill Ferson,
86, 17 years
 Dick Tompkins,
78, 2 years
 „Retirement is a
dirty word“
http://www.vitaneedle.com
From „burden“ …
Age
1.032
858
10
794
679
20
657
957
40
1.111
1.340
50
1.703
1.732
65
2.826
2.493
75
4.197
3.658
90
5.371
4.903
1
The Burden of An Ageing Population
Health Care Spending in Germany
Re: German igsf 2005
… to „profitable business
models“
Bln €
50
40
35,60
37,12
38,73
40,42
42,20
44,08
0,95 Health& Literature
3,66 Pharmaproducts/
Cosmetics
30
4,06 Health & Food
20
6,60 Massages,
Physiotherapy
10
11,07 Health & Cures
Health & Vacation
0
1998
1999
2000
2001
2002
Turnover in Bln. € of the
Well-being Industry in
Germany
2003
17,74 Fitnes & Sports
Course of baths
World market of Medical
Technology
Others
16%
2006
Total Volume
260 Bln €
Europe 20
(without %
Germany)
10%
43
%
USA
11%
Germany
It is a huge market …
Re: Frankfurter Allgemeine Zeitung,
01.07.2006
Japan
… with a high
Innovation rate !!!
 North Eastern Germany
 Located in between
metropolitan areas Berlin,
Hamburg, Copenhagen
Rostock
Greifswald
 Population approx.
1,8 million (= Hamburg)
Schwerin
 Area approx. 23.000 km ²
 Approx. 80 inhabitants /km ²
 Rostock largest city
(200.000 habitants)
Challenges:
 Maritime countryside with
more than 1.000 km coast
- No big industry
line and more than 1000
- Remote location within Germany lakes
- Limited financial resources
- Demographic development
„Public Private Partnership“
 Bundle forces and
 Stimulate cooperation between
research & industry
 Promote regional/ international
cooperation
BioCon Valley GmbH
Capital Company
Land Mecklenburg-Vorpommern ~51%
BioCon Valley e.V. ~27%
Financial institutions ~20%
BioCon Valley e.V.
Non profit association
~160 members (companies, universities,
research institutions, service providers,
hospitals, hotels, ...)
© BioCon Valley® GmbH · Greifswald / Rostock
15
Sectoral focus
• Blue (marine) biotechnology
• Green biotechnology
(agriculture, nutrition)
• Red biotechnology
• Medical technology
• White (industrial) biotechnology
• Prevention/
Health promotion
• Health Tourism
• Silver economy
(Successful ageing)
• Rehabilitation
• Food &
nutrition
© BioCon Valley® GmbH · Greifswald / Rostock
16
Employees in health economy
Main Sector
Ambulante / inpatient medicare
Administration, chemist‘s, health and
spa business, self-help
61.745
13.279
Pre- service and supply industrie
(handcraft, medical technology,
pharmaceutical industry, ...)
5.790
Sub sectors and boundary area of the
health care
~ 15% of MV employees
work in/for health sector!
5.444
86.258
© BioCon Valley® GmbH · Greifswald / Rostock
17
2. Health Care Industry as a growth and employment driver?
Ranking of the federal states of Germany (impact of the GVA)
MV in comparison (Wifor)
Turnover MV: ~ 3.5 – 4 Bio. €
Rank
2006
GVA in %
2006
Rank
1996
Differences
1996-2006
MecklenburgVorpommern
1
13,7
1
+2,7
Berlin
2
13,4
4
+3,0
Sachsen-Anhalt
3
12,9
5
+2,5
Thüringen
4
12,8
2
+2,0
Brandenburg
5
12,2
6
+2,0
Source: Destatis, 2009; BA 2009; Berechnung: Wertschöpfungsansatz, WifOR, 2010.
The impact of the HCI is especially in economically underdeveloped
regions very high.
© 2010 WifOR | Dr. Dennis A. Ostwald | Healthcare Industry: Growth and employment driver?
12 | 18
Masterplan
Health Economy MV 2020
Food and nutrition
Life Sciences
(Biotech, Pharma,
Medtech)
Health Care
Primary sector
Health services
Health tourism
Healthy
Ageing
© BioCon Valley® GmbH · Greifswald / Rostock
19
Healthy ageing
Masterplan Health Economy MV 2014 - 2020
Quality
of life
Work &
productivity
Education &
Culture
Living environment
& mobility
Health &
wellbeing
© BioCon Valley® GmbH · Greifswald / Rostock
20
Key spots
driversinin
Hot
Mode 3 clusters
Co-location clusters
Scientific fountains
Life sciences
and Health
 Stable health care systems
affecting a population of
approx. 85 Mio. people
 More than 5 Mio.
Employees in health care
and related industries
 Critical mass of innovative
universities with world class
basic science with a general
strong focus on life sciences
 Well educated, skillful and
motived human ressources
 Strong health care/pharma/
medtech industry with more
than 2.000 companies
Virology
Physiology
Pharmacology
Oncology
Neurosciences
high
Multidisc. Sciences
Microbiology
Medical Informatics
Biomaterials
Infectious Diseases
Immunology
Hematology
Genetics & Heredity
Biomed. Engineering
Endocrinology
Developmental Biology
Cell Biology
0,8-1
0,6-0,8
0,4-0,6
0,2-0,4
0-0,2
Cardiovascular
Biotechnology
Biophysics
Biochem. & Mol. Biol.
Regional hot spots in life science
ScanBalt CompetenceRegion LSHMCT-2004-503406: Benchmark
analysis on quantitative and
qualitative data
low
London
Boston
Stockholm
ScanBalt 13
ScanBalt 10
Cooperation
between regions
„Competence
Satellites“
„Competence
hubs“
„Competence
Satellites“
„Competence
Satellites“
ScanBalt catalyzer for interactions:
Exchange of human capital, knowledge, innovation;
EU FP7 proposals, joint projects; strategy development; …
European Strategy
for the Baltic Sea
 4 challenges
(main focus areas)




environmental sustainability,
prosperity,
attractiveness and
safety / security.
 10 horizontal actions
 15 objectives (priority areas)
 > 80 flagship projects
Flagship
ScanBalt
Health Region
Flagship project
„Baltic Sea Health Region“
 Long title: “Set up cross-sectoral reference projects
for innovation in health and life sciences”
 Objectives:




… promotion of public health on a high level
… exploitation of modern life sciences
… innovations in science, technology and social science
Baltic Sea Region as a model for
providing the basis for a knowledge-based economy and
for implementing a shared strategy
BSHR is an open
 Lead Partners:
structure, partners
welcome!
 BioCon Valley (Germany)
 Lithuanian Biotechnology Association (Lithuania)
 ScanBalt and ScanBalt Academy
Challenges
 Political governance usually
distributed in different
ministries
 Reimbursement schemes or
business models vary
between social systems and
privately financed health
systems
 High market pressure for
innovation in very different
areas from high tech products
to innovative but low tech
services
 Actors from separate sectors
with different
communication and
business cultures
Action lines
 Install communication & governance platform and start a
sustainable, „directed“ (bottom up resp. top down) and crosssectoral consultation process
– Prio. 7
– Prio. 12
– Prio. 8
BSR Stardust („Innovation“)
Northern Dimension („Health“)
ICT for Health („ICT“)
 Initiate transnational strategy development process based
upon regional consortia and interests
 Initiate and support project consortia in common areas of
interest
 Create a macro-regional model for transnational cooperation in
the strategically important area of health and life sciences
ScanBalt & Healthy Ageing
• Participation in Active for Life - Project
– Establish cooperation platform
– Align regional strategies for ageing and wellbeing
• ScanBalt Position Paper on Healthy Ageing
– From Biological Fundaments to Clinical Solutions
– Basis research, Population research,
Development of products and processes, Public
private partnership models
– Developmental focus areas eg. Ageing Brain,
Healthy food and nutrition, Technologies for
Ageing people, Healthy Ageing at work, E-health
What is in for the regions?
Importance of Health care related industries concerning employment
1996
Source: WifOR 2010 (www.hci-compass.com ); Database: BA, 2009;
Fed. Statistical Office, 2009.
2006
Health and structural fonds
2007 - 2013
• Total Structural funds
– Convergence (Phasing out)
81,5%
– Competitiveness
16,0%
– Territorial Cooperation
2,5%
347,8 Bio. €
282.8 Bio. €
55.0 Bio. €
8.7 Bio. €
• Investments in health
– Direct health investment
– Indirect health investment
– Not health investment
5 Bio. € 1,4%
??
??
10. ScanBalt
Forum
„10 Years ScanBalt
BioRegion –
Towards a Balanced
Regional Development and
Smart Specialization in the
Baltic Sea Region”
Thank you !
21. – 24. Sept 2011
Thank you !
Global interview project
Conference 2010 Göteborg,
www.omep2010.org
By courtesy: Bo Samuelsson, Göteborg
ScanBalt –
a string of competency clusters
BioCon Valley
Current
Impact
Biotech
Workforce
Human
Capital
„mode-3“
Bio Turku
BioTeamSouth
Kalmar
BioScience
Estonia Biotech
Lithuania Biotech
MedCoast
Scandinavia
Latvia Biotech
Medicon Valley
North Poland
Biotech
North-West Russia
Biotech
Risk Capital
R&D Input
„scientific fountain“
Helsinki
Stockholm
[Berlin]
[Hamburg]
„co-location“
2. Health Care Industry as a growth and employment driver?
Ranking of the federal states of Germany (impact of the employment)
MV in comparison (Wifor)
Rank
2006
Emp. in %
2006
Rank
1996
Differences
1996-2006
Berlin
1
15,8
1
+2,0
MecklenburgVorpommern
2
15,1
2
+2,1
Sachsen-Anhalt
3
14,6
7
+2,2
Brandenburg
4
14,2
9
+2,2
Schleswig-Holstein
5
14,1
3
+1,2
Source: Destatis, 2009; BA 2009; Berechnung: Wertschöpfungsansatz, WifOR, 2010.
The same conclusion can be made for the employment.
© 2010 WifOR | Dr. Dennis A. Ostwald | Healthcare Industry: Growth and employment driver?
13 | 18
Health and structural fonds
2007 - 2013
• Health expenditures in all EU countries range
from 4.9 to 10.7% of GDP
• Described in strategic reference framework
and operational programmes
– „Direct“ and „indirect health investment“
• E.g. health infrastructure, e-health, inpatient care, access
to healthcare by vulnerable social groups, emergency
care, medical equipment, screening, health and safety at
work, health promotion and disease prevention,
education and training for health professionals
– Non health sector investment
with potential health gain
Health & wealth
 “Health Economy” sector provides more jobs and
generates more income than many “traditional”
sectors, like automotive, agriculture or food industry.
 Health Economy is a pillar of knowledge-based
society, which allows the Baltic sea region to
compete with Asia and the US.
 Investment in health fosters long term growth and
sustainability of economies.
 Health Economy has proven to reduce the negative
effects of the economic crisis and prepare for a time
after the crisis.
Flagship Strategy
• Mission:
“Set up cross-sectoral and transnational reference
projects for collaboration and innovations in health
and in life sciences in order to promote public health
on a high and sustainable level and to make Baltic
Sea Region a globally leading and prosperous metaregion within health.”
• Draft of strategy paper,
to be published at ScanBalt Forum 2010 in Tallinn
Action lines
 Install communication & governance platform and start a
sustainable, „directed“ (bottom up resp. top down) and crosssectoral consultation process
– Prio. 7
– Prio. 12
– Prio. 8
BSR Stardust („Innovation“)
Northern Dimension („Health“)
ICT for Health („ICT“)
 Initiate transnational strategy development process based
upon regional consortia and interests
 Initiate and support project consortia in common areas of
interest
 Create a macro-regional model for transnational cooperation in
the strategically important area of health and life sciences
German-Monitoring:
Growth driver Health care industry
GVA growth rate for the national economy and Health care industry
7.00%
GVA annual percentage change
6.00%
5.00%
4.00%
Ø 3,4% p.a.
3.00%
Ø 1,9% p.a.
2.00%
1.00%
0.00%
1997
1998
1999
2000
2001
2002
2003
-1.00%
health care
rel. industry
GVAGVA
national
economy
Growth rate of the health
care industry is aboveaverage compared to the
national economy
2004
2005
2006
2007 * 2008 *
GVA
national economy
GVA
healthcare
industry
* Database:
2nd respectively 3rd extrapolation
of the NA
Source:
WifOR 2010; Database: Fed. Statistical
Office, 2009.
German-Monitoring:
Job driver Health care industry
Growth rate of employment
2.50%
4,700
2.00%
4,500
1.50%
4,300
1.00%
4,100
0.50%
3,900
0.00%
3,700
-0.50%
3,500
-1.00%
1997
1998
1999
2000
2001
2002
healthcare industry employees (%)
national economy employees (%)
In recent years the Health
care industry has set up an
above-average employment
in Germany.
2003
2004
2005
2006
2007
*
2008
*
healthcare industry employees
* Database:
2nd respectively 3rd extrapolation
of the NA
Source:
WifOR 2010; Database: Fed. Statistical
Office, 2009.
Employment annual percentage change
Employees in 1.000
4,900
Health – share of GDP
Source: OECD Health Data 2009, OECD (http://www.oecd.org/health/healthdata).